Paolo Macor
Università degli Studi di Trieste
H-index: 32
Europe-Italy
Top articles of Paolo Macor
Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models
Frontiers in Immunology
2023/6/8
Paolo Macor
H-Index: 20
C9 immunostaining as a tissue biomarker for periprosthetic joint infection diagnosis
Frontiers in Immunology
2023/2/21
Paolo Macor
H-Index: 20
Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome
2023/1/9
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma
Journal of Translational Medicine
2023/11/28
Paolo Macor
H-Index: 20
Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles
Journal of Nanobiotechnology
2023/10/14
Federico Colombo
H-Index: 4
Paolo Macor
H-Index: 20
A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy
2023/9/18
Paolo Macor
H-Index: 20
243 Anti-GPC1 IgM activating the complement system is an effective treatment in a pancreatic ductal adenocarcinoma mouse model
Immunobiology
2023/9/1
Paolo Macor
H-Index: 20
Plasminogen activator-coated nanobubbles targeting cell-bound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy
Haematologica
2023/7/7
Paolo Macor
H-Index: 20
Francesco Tedesco
H-Index: 36
Biological features of nanoparticles: protein corona formation and interaction with the immune system
2022/11/26
Paolo Macor
H-Index: 20
Nanocarriers as a delivery platform for anticancer treatment: biological limits and perspectives in B-cell malignancies
2022/9/17
Paolo Macor
H-Index: 20
Zebrafish: a useful animal model for the characterization of drug-loaded polymeric NPs
Biomedicines
2022/9/11
Paolo Macor
H-Index: 20
The proteoglycan glypican-1 as a possible candidate for innovative targeted therapeutic strategies for pancreatic ductal adenocarcinoma
2022/9/7
Paolo Macor
H-Index: 20
Novel nanotechnology approaches to overcome drug resistance in the treatment of hepatocellular carcinoma: glypican 3 as a useful target for innovative therapies
2022/9/2
Paolo Macor
H-Index: 20
Analysis of autoantibodies and complement activation in bronchoalveolar lavage of COVID-19 patients
Molecular Immunology
2022
Francesco Tedesco
H-Index: 36
Paolo Macor
H-Index: 20
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination
Journal of Autoimmunity
2021/11/1
The inflammatory feed-forward loop triggered by the complement component C3 as a potential target in endometriosis
Frontiers in Immunology
2021/8/13
Multiple-organ complement deposition on vascular endothelium in COVID-19 patients
Biomedicines
2021/8/12
Paolo Macor
H-Index: 20
Alessandro Mangogna
H-Index: 8
Nicola Pozzi
H-Index: 16
Francesco Tedesco
H-Index: 36
An allosteric redox switch in domain V of β2-glycoprotein I controls membrane binding and anti-domain I autoantibody recognition
Journal of Biological Chemistry
2021/8/1
Nanoparticles-based oligonucleotides delivery in cancer: role of zebrafish as animal model
2021/7/21
Paolo Macor
H-Index: 20
Constitutive PSGL-1 correlates with CD30 and TCR pathways and represents a potential target for immunotherapy in anaplastic large T-cell lymphoma
Cancers
2021/6/12
